Liver transplantation benefits selected patients with hilar cholangiocarcinoma and colorectal liver metastases

作     者：Ji-Qiao Zhu Qiang He Xian-Liang Li 

作者机构：Department of Hepatobiliary and Pancreatic Surgery Beijing Chaoyang Hospital Capital Medical University 

出 版 物：《Hepatobiliary & Pancreatic Diseases International》 (国际肝胆胰疾病杂志（英文版）)

年 卷 期：2018年第17卷第5期

页      面：385-386页

核心收录：

学科分类：10[医学] 

基　　金：supported by grants from the National Natural Science Foundation of China(81571554 and 81273270) 

主　　题：Liver transplantation benefits selected patients with hilar cholangiocarcinoma and colorectal liver metastases 

摘      要：Hilarcholangiocarcinoma(HCCA)isanaggressivemalignancy with a dismal prognosis. The 5-year survival rate has been reported to range from 39%to 50%if an R0 resection is obtained [1]. Approximately 25%patients with early stage HCCA of all cases can be treated with radical surgical resection [2], while most patients do not have a chance to receive a surgical procedure due to the advanced stage at the time of diagnosis. The poor prognosis is gen-